Suggestions
Baird Radford
Chief Financial Officer at Allakos Inc.
Baird Radford is the Chief Financial Officer (CFO) at Allakos Inc., a biotechnology company focused on developing therapies for allergic and inflammatory diseases. He joined Allakos in April 2022, bringing over 25 years of extensive finance and leadership experience from various public companies across multiple industries.
Professional Background
-
Aimmune Therapeutics: Prior to his role at Allakos, Radford served as Senior Vice President of Finance at Aimmune Therapeutics, where he was instrumental in the financial operations supporting the launch of the company's first approved product. His responsibilities included overseeing strategic and operational finance activities, financial planning, controllership, tax, and treasury functions.124
-
HeartFlow: Radford was also the CFO at HeartFlow, a medical technology firm with operations in North America, Europe, and Japan. His leadership there contributed to the company's financial strategies during its growth phase.24
-
Intuitive Surgical and eBay: Before HeartFlow, he held significant roles at Intuitive Surgical as Vice President of Finance and had various positions at eBay, including Vice President of Finance for Marketplaces Europe. His experience spans financial planning, analysis, investor relations, and enterprise analytics.23
-
Early Career: Radford began his career in the audit practice at PricewaterhouseCoopers, which laid a strong foundation for his subsequent roles in finance leadership.4
Education
Baird Radford holds a Bachelor of Business Administration (BBA) from Ohio University. This academic background complements his extensive professional experience in finance and corporate leadership.24
Radford's expertise is particularly valuable to Allakos as the company navigates the transition from research and development to commercialization of its lead product candidate, lirentelimab (AK002), which is currently undergoing clinical trials.13

